comparemela.com

Latest Breaking News On - Hormone products - Page 5 : comparemela.com

Ozempic Is the New Guest at Thanksgiving This Year

People taking weight-loss and diabetes drugs feel a sense of freedom as well as fear of judgment from family as they prepare for holiday gatherings

Zohray brennanHealthcare life sciencesSpecialized drugs medicationsHormone productsDiabetes drugsNorth americaUnited statesPolitical general newsMedical conditionsWsj pro comLink i1 wp wsj 0001376372Link i3 wp wsj 0001376372Link i5 wp wsj 0001376372Link i2 wp wsj 0001376372Link i4 wp wsj 0001376372General news

Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences

By Denny Jacob Getty Images Holdings lowered its 2023 outlook, citing challenges ranging from strikes in Hollywood to a stronger dollar. Shares retreat 5.8%.

United statesDenny jacobDrug administrationGetty images holdingsImages holdingsDuchenne muscular dystrophyArticle normalBiotechnology servicesHealthcare life sciencesBiological therapySpecialized drugs medicationsHormone productsHealthcare provisionContent typesFactiva filtersC amp ampe exclusion filter

Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds

Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road

United statesJulie stichEil lilly coAmerican medical association onInternational foundation of employee benefitPfizer incDrug administrationInternational foundationEmployee benefit plansAmerican medical associationEil lillyArticle normalAgricultural machineryRetail wholesaleNon life insuranceHealth medical insurance

TherapeuticsMD to Consider Strategic Alternatives

By Josh Beckerman TherapeuticsMD, which owns the rights to pharmaceutical royalties, will consider strategic alternatives such as an acquisition, merger or.

Josh beckermanMayne pharma groupMayne pharmaArticle normalHealthcare life sciencesSpecialized drugs medicationsHormone productsCorporate industrial newsMyx auAu myxIndustrial newsLife sciencesSpecialized drugs

Diabetes stocks are surprise winners from Novo Nordisk s Wegovy study, analysts say

Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits

Eli lillyNovo nordiskRaymond jamesDrug administrationIntuitive surgical incDexcom incDavita incInsulet corpLeerink partnersIntuitive surgicalArticle normalCardiovascular drugsMedical equipment suppliesPrinting publishingPort harbor operationsHealthcare life sciences

vimarsana © 2020. All Rights Reserved.